COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges

COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges

Multiple vaccines have recently been developed, and almost all the countries are presently vaccinating their population to tackle the COVID-19 pandemic. Most of the COVID-19 vaccines in use are administered via intramuscular (IM) injection, eliciting protective humor and cellular immunity. COVID-19...

Full description

Bibliographic Details
Main Authors: Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, Talha Bin Emran, Saikat Mitra, Ali A. Rabaan, Saad Alhumaid, Zainab Al Alawi, Abbas Al Mutair
Format: Article
Language:English
Published: Taylor & Francis Group 2022-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
covid-19
sars-cov-2
intranasal vaccine
mucosal immunity
Online Access:http://dx.doi.org/10.1080/21645515.2022.2045853

Internet

http://dx.doi.org/10.1080/21645515.2022.2045853

Similar Items